ANIKA THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.59 USD | +0.12% |
|
-9.77% | +12.93% |
| 08/05 | Transcript : Anika Therapeutics, Inc., Q1 2024 Earnings Call, May 08, 2024 | |
| 08/05 | Earnings Flash (ANIK) ANIKA THERAPEUTICS Reports Q1 EPS $0.09 | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 379M | - | - | - | |||
| 89.46B | ||||||
| 40.74B | ||||||
| 33.03B | ||||||
| 24.68B | ||||||
| 15.12B |
